Novo Holdings participates in series B round at Belgian cancer firm
![Photo: Novo Holdings / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13742125.ece/ALTERNATES/schema-16_9/doc7jqxnx6vli8qh9hr7pz.jpg)
Belgian biotech firm Precirix has finished a series B financing round raising EUR 80m, a press release reports.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Gilde Healthcare closes oversubscribed fund
For subscribers
Novo Holdings appoints new CFO
For subscribers